🔗 Share this article

A shadow market for unlicensed weight-loss drugs is being driven by social media fitness personalities and vendors on messaging platforms, based on recent findings.

Investigational Treatment Gaining Popularity Via Social Media

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its supposed weight-reducing properties. Viewers are encouraged to contact these accounts directly for supplier links, while also receiving discount codes.

Active Trade on Social Networks

Separately, a robust market exists on messaging services, where communities with numerous of members share “before and after” photos, administration instructions and claims of rapid UK delivery. Sellers market the substance there before directing customers to other platforms for transactions.

Learning About The Experimental Drug

Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help patients lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.

Medical Professionals Express Concerns

However, doctors and chemists have cautions that the sale of what remains an unlicensed drug in the UK is a cause for concern and could result in users injecting substances of unknown origin.

Several experts stated the demand for the experimental drug could be connected to the rising cost of approved weight loss treatments such as Mounjaro.

Regulatory Status and Enforcement

Marketing retatrutide on social media or Telegram is illegal in the UK, as it is an unapproved drug that must not be promoted or supplied for human use under the British medical regulations.

Several content creators try to sidestep the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still violate pharmaceutical, advertising, and consumer regulations, risking penalties, prosecution or prison.

Service Response and Content Elimination

Based on TikTok, the platform has taken down problematic content and prohibited associated hashtags and query recommendations. The organization stated it was dedicated to keeping the service secure and allocating resources in enhancing compliance measures.

Online Marketplace Operations

Research also found communities with up to 9,000 members marketing the experimental drug using Telegram's integrated search feature, which operates like a public directory. Typing “retatrutide” immediately brings up channels with thousands of users, filled with photos of weight loss, positive reviews and step-by-step guides for preparing or administering at home.

After minutes of entering one community, a seller shared WhatsApp details, where most transactions occur. The seller sent an instruction manual and guaranteed delivery within 48 hours. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one inquired about weight, health issues or past usage.

Item Information and Costs

Inside these groups, posts show dark colored packages with postal service labels, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at residence with sterile water, or pre-filled injectors typically priced at 160 pounds for 20mg. When questioned how much time a injector should last, sellers give contradictory responses varying between a several days to “depends on your body”.

Platform Oversight and Security Measures

A spokesperson for the messaging service stated it regularly monitored dangerous material on its platform including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are injecting materials they can’t verify. Even if the science behind retatrutide is valid, these digital products may not include what they claim,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor connected the increase in demand to recent price rises for approved slimming drugs such as Mounjaro. “With prices rising, individuals are using online platforms. But fake treatments are extremely risky. You cannot know what’s contained or whether the conditions they were made in was sterile,” she explained.

Her team has already seen individuals injured by personal administration from unverified suppliers. “We recognize the disappointment, but buying from messaging apps or communication platforms is gambling with your health,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Position

A spokesperson from the pharmaceutical company said retatrutide was in third stage research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for personal consumption,” they said, noting that any product “falsely representing itself as a company investigational product not yet authorized … may subject patients to possibly significant health risks”.